Group One Trading
KURA icon

Group One Trading’s Kura Oncology KURA Stock Holding History

Group One Trading’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Sell
36,600
-14,500
-28% -$125K ﹤0.01% 3806
2025
Q4 		$531K Buy
51,100
+23,400
+84% +$246K ﹤0.01% 3442
2025
Q3 		$245K Buy
27,700
+5,500
+25% +$39.2K ﹤0.01% 4453
2025
Q2 		$128K Buy
22,200
+7,100
+47% +$43.5K ﹤0.01% 4746
2025
Q1 		$99.7K Sell
15,100
-12,000
-44% -$93.5K ﹤0.01% 4602
2024
Q4 		$236K Buy
+27,100
New +$390K ﹤0.01% 3808
2024
Q3 		– Sell
-2,600
Closed -$53.5K – 7006
2024
Q2 		$53.5K Sell
2,600
-7,100
-73% -$146K ﹤0.01% 4482
2024
Q1 		$207K Buy
9,700
+9,200
+1,840% +$179K ﹤0.01% 3534
2023
Q4 		$7.19K Sell
500
-10,000
-95% -$98.3K ﹤0.01% 6358
2023
Q3 		$95.8K Hold
10,500
– – ﹤0.01% 4499
2023
Q2 		$111K Buy
10,500
+3,200
+44% +$37.8K ﹤0.01% 4507
2023
Q1 		$89.3K Sell
7,300
-36,700
-83% -$458K ﹤0.01% 4393
2022
Q4 		$546K Buy
44,000
+36,100
+457% +$525K ﹤0.01% 2969
2022
Q3 		$108K Sell
7,900
-13,600
-63% -$210K ﹤0.01% 4709
2022
Q2 		$394K Sell
21,500
-2,700
-11% -$38.8K ﹤0.01% 3647
2022
Q1 		$389K Sell
24,200
-21,200
-47% -$306K ﹤0.01% 4079
2021
Q4 		$636K Sell
45,400
-6,900
-13% -$112K ﹤0.01% 3848
2021
Q3 		$980K Buy
52,300
+51,900
+12,975% +$978K ﹤0.01% 3439
2021
Q2 		$8K Sell
400
-1,700
-81% -$42.2K ﹤0.01% 7602
2021
Q1 		$59K Sell
2,100
-11,300
-84% -$358K ﹤0.01% 6106
2020
Q4 		$438K Sell
13,400
-19,800
-60% -$696K ﹤0.01% 3378
2020
Q3 		$1.02M Buy
33,200
+30,200
+1,007% +$667K ﹤0.01% 2177
2020
Q2 		$49K Buy
+3,000
New +$43.3K ﹤0.01% 4374
2018
Q4 		– Sell
-200
Closed -$4K – 5149
2018
Q3 		$4K Sell
200
-400
-67% -$7.67K ﹤0.01% 4906
2018
Q2 		$11K Buy
600
+200
+50% +$3.39K ﹤0.01% 4585
2018
Q1 		$8K Buy
400
+100
+33% +$1.95K ﹤0.01% 4388
2017
Q4 		$5K Buy
+300
New +$4.42K ﹤0.01% 4561

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's KURA Position: Q1 2026 in Review

Group One Trading sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 65,012 shares — an estimated $558K sold.

Group One Trading first reported a position in KURA in Q1 2018 and held it in 18 quarters. The position peaked at $678K in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Group One Trading reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 65,012 Kura Oncology shares in Q1 2026, an estimated $558K.
  • Group One Trading first reported a position in Kura Oncology in Q1 2018 and held it in 18 quarters.
  • Group One Trading's Kura Oncology position peaked at $678K in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.